Human mesenchymal stem cells and renal tubular epithelial cells differentially influence monocyte-derived dendritic cell differentiation and maturation

Cellular Immunology

Volumn 267, Issue 1, 2011, Pages 30-38

  Kronsteiner, Barbara ^a,b,c   Peterbauer Scherb, Anja ^a,c   Grillari Voglauer, Regina ^d   Redl, Heinz ^b,c   Gabriel, Christian ^a,c   van Griensven, Martijn ^b,c   Wolbank, Susanne ^b,c  

^a Red Cross Transfusion Service of Upper Austria   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^c Austrian Cluster for Tissue Regeneration ^*  (Austria)

^d UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

Author keywords

Dendritic cells; Immunomodulation; Mesenchymal stem cells; Renal tubular epithelial cells

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ANTIGEN; LEUKOCYTE ANTIGEN G; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE CELL; ADULT; AMNIOTIC FLUID CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL POPULATION; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TUBULE EPITHELIUM; MESENCHYMAL STEM CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

ADULT; CELL DIFFERENTIATION; CELL SURVIVAL; COCULTURE TECHNIQUES; DENDRITIC CELLS; EPITHELIAL CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; KIDNEY TUBULES; MESENCHYMAL STEM CELLS; MIDDLE AGED; MONOCYTES; YOUNG ADULT;

EID: 78651060858     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2010.11.001     Document Type: Article

References (53)

1. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
2. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., Benhaim P., Lorenz H.P., Hedrick M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.
3. Fukuchi Y., Nakajima H., Sugiyama D., Hirose I., Kitamura T., Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004, 22:649-658.
4. Bajada S., Mazakova I., Richardson J.B., Ashammakhi N. Updates on stem cells and their applications in regenerative medicine. J. Tissue Eng. Regen. Med. 2008, 2:169-183.
5. Le Blanc K., Rasmusson I., Gotherstrom C., Seidel C., Sundberg B., Sundin M., Rosendahl K., Tammik C., Ringden O. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand. J. Immunol. 2004, 60:307-315.
6. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., Gianni A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
7. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A., Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 2002, 30:42-48.
8. Spaggiari G.M., Capobianco A., Becchetti S., Mingari M.C., Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006, 107:1484-1490.
9. Rasmusson I., Ringden O., Sundberg B., Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003, 76:1208-1213.
10. Corcione A., Benvenuto F., Ferretti E., Giunti D., Cappiello V., Cazzanti F., Risso M., Gualandi F., Mancardi G.L., Pistoia V., Uccelli A. Human mesenchymal stem cells modulate B-cell functions. Blood 2006, 107:367-372.
11. Jiang X.X., Zhang Y., Liu B., Zhang S.X., Wu Y., Yu X.D., Mao N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005, 105:4120-4126.
12. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
13. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., Muul L., Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. USA 2002, 99:8932-8937.
14. Le Blanc K., Rasmusson I., Sundberg B., Gotherstrom C., Hassan M., Uzunel M., Ringden O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004, 363:1439-1441.
15. Garcia-Olmo D., Garcia-Arranz M., Herreros D., Pascual I., Peiro C., Rodriguez-Montes J.A. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis. Colon Rectum 2005, 48:1416-1423.
16. Haniffa M.A., Wang X.N., Holtick U., Rae M., Isaacs J.D., Dickinson A.M., Hilkens C.M., Collin M.P. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J. Immunol. 2007, 179:1595-1604.
17. Jones S., Horwood N., Cope A., Dazzi F. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J. Immunol. 2007, 179:2824-2831.
18. de Haij S., Woltman A.M., Trouw L.A., Bakker A.C., Kamerling S.W., van der Kooij S.W., Chen L., Kroczek R.A., Daha M.R., van Kooten C. Renal tubular epithelial cells modulate T-cell responses via ICOS-L and B7-H1. Kidney Int. 2005, 68:2091-2102.
19. Ding H., Wu X., Gao W. PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis. Clin. Immunol. 2005, 115:184-191.
20. Waeckerle-Men Y., Starke A., Wuthrich R.P. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells. Nephrol. Dial. Transplant. 2007, 22:1527-1536.
21. Singer G.G., Yokoyama H., Bloom R.D., Jevnikar A.M., Nabavi N., Kelley V.R. Stimulated renal tubular epithelial cells induce anergy in CD4+ T cells. Kidney Int. 1993, 44:1030-1035.
22. van Kooten C., Daha M.R., van Es L.A. Tubular epithelial cells: a critical cell type in the regulation of renal inflammatory processes. Exp. Nephrol. 1999, 7:429-437.
23. Kelley V.R., Singer G.G. The antigen presentation function of renal tubular epithelial cells. Exp. Nephrol. 1993, 1:102-111.
24. Starke A., Lindenmeyer M.T., Segerer S., Neusser M.A., Rusi B., Schmid D.M., Cohen C.D., Wuthrich R.P., Fehr T., Waeckerle-Men Y. Renal tubular PD-L1 (CD274) suppresses alloreactive human T-cell responses. Kidney Int. 2010, 78:38-47.
25. Waeckerle-Men Y., Starke A., Wahl P.R., Wuthrich R.P. Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation. Kidney Blood Press. Res. 2007, 30:421-429.
26. Beyth S., Borovsky Z., Mevorach D., Liebergall M., Gazit Z., Aslan H., Galun E., Rachmilewitz J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005, 105:2214-2219.
27. Chen L., Zhang W., Yue H., Han Q., Chen B., Shi M., Li J., Li B., You S., Shi Y., Zhao R.C. Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells. Stem Cells Dev. 2007, 16:719-731.
28. Djouad F., Charbonnier L.M., Bouffi C., Louis-Plence P., Bony C., Apparailly F., Cantos C., Jorgensen C., Noel D. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 2007, 25:2025-2032.
29. English K., Barry F.P., Mahon B.P. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol. Lett. 2008, 115:50-58.
30. Jung Y.J., Ju S.Y., Yoo E.S., Cho S.J., Cho K.A., Woo S.Y., Seoh J.Y., Park J.W., Han H.S., Ryu K.H. MSC-DC interactions: MSC inhibit maturation and migration of BM-derived DC. Cytotherapy 2007, 9:451-458.
31. Li Y.P., Paczesny S., Lauret E., Poirault S., Bordigoni P., Mekhloufi F., Hequet O., Bertrand Y., Ou-Yang J.P., Stoltz J.F., Miossec P., Eljaafari A. Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J. Immunol. 2008, 180:1598-1608.
32. Magatti M., De Munari S., Vertua E., Nassauto C., Albertini A., Wengler G.S., Parolini O. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant. 2009, 18:899-914.
33. Nauta A.J., Kruisselbrink A.B., Lurvink E., Willemze R., Fibbe W.E. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J. Immunol. 2006, 177:2080-2087.
34. Ramasamy R., Fazekasova H., Lam E.W., Soeiro I., Lombardi G., Dazzi F. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 2007, 83:71-76.
35. Spaggiari G.M., Abdelrazik H., Becchetti F., Moretta L. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 2009, 113:6576-6583.
36. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
37. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
38. Reis e Sousa C. Activation of dendritic cells translating innate into adaptive immunity. Curr. Opin. Immunol. 2004, 16:21-25.
39. Wolbank S., Peterbauer A., Fahrner M., Hennerbichler S., van G.M., Stadler G., Redl H., Gabriel C. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 2007, 13:1173-1183.
40. Wieser M., Stadler G., Jennings P., Streubel B., Pfaller W., Ambros P., Riedl C., Katinger H., Grillari J., Grillari-Voglauer R. HTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am. J. Physiol. Renal Physiol. 2008, 295:F1365-F1375.
41. Lutz M.B., Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol. 2002, 23:445-449.
42. Groh M.E., Maitra B., Szekely E., Koc O.N. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp. Hematol. 2005, 33:928-934.
43. Corinti S., Albanesi C., la Sala A., Pastore S., Girolomoniii G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 2001, 166:4312-4318.
44. Kaur K., Dhingra S., Slezak J., Sharma A.K., Bajaj A., Singal P.K. Biology of TNFalpha and IL-10 and their imbalance in heart failure. Heart Fail. Rev. 2009, 14:113-123.
45. Kalinski P., Hilkens C.M., Snijders A., Snijdewint F.G., Kapsenberg M.L. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 1997, 159:28-35.
46. English K., Ryan J.M., Tobin L., Murphy M.J., Barry F.P., Mahon B.P. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin. Exp. Immunol. 2009, 156:149-160.
47. Rutella S., Bonanno G., Procoli A., Mariotti A., de Ritis D.G., Curti A., Danese S., Pessina G., Pandolfi S., Natoni F., Di Febo A., Scambia G., Manfredini R., Salati S., Ferrari S., Pierelli L., Leone G., Lemoli R.M. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood 2006, 108:218-227.
48. Carosella E.D., Moreau P., Lemaoult J., Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol. 2008, 29:125-132.
49. Crispim J.C., Duarte R.A., Soares C.P., Costa R., Silva J.S., Mendes-Junior C.T., Wastowski I.J., Faggioni L.P., Saber L.T., Donadi E.A. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. Transpl. Immunol. 2008, 18:361-367.
50. Rebmann V., Bartsch D., Wunsch A., Mollenbeck P., Golda T., Viebahn R., Grosse-Wilde H. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation. Hum. Immunol. 2009, 70:995-999.
51. Gros F., Cabillic F., Toutirais O., Maux A.L., Sebti Y., Amiot L. Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells. Eur. J. Immunol. 2008, 38:742-749.
52. van den Berk L.C., Roelofs H., Huijs T., Siebers-Vermeulen K.G., Raymakers R.A., Kogler G., Figdor C.G., Torensma R. Cord blood mesenchymal stem cells propel human dendritic cells to an intermediate maturation state and boost interleukin production by mature dendritic cells. Immunology 2009, 128:564-572.
53. Chomarat P., Banchereau J., Davoust J., Palucka A.K. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 2000, 1:510-514.